Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Buccisano

Showing results (31-40 of 143) with videos related to

Pageof 15
Sort By:
Leukemia|March 24, 2021
Measurable residual disease as a biomarker in acute myeloid leukemia: theoretical and practical considerationsRoland B Walter, Yishai Ofran, Agnieszka Wierzbowska, et al.
Mediterranean Journal of Hematology and Infectious Diseases|September 14, 2023
Therapy-related Myeloid Neoplasms: Considerations for Patients' Clinical EvaluationRaffaele Palmieri, Giovangiacinto Paterno, Flavia Mallegni, et al.
Frontiers in Immunology|May 13, 2017
FCγ Chimeric Receptor-Engineered T Cells: Methodology, Advantages, Limitations, and Clinical RelevanceSara Caratelli, Tommaso Sconocchia, Roberto Arriga, et al.
Biomedicines|February 25, 2023
Measurable Residual Disease and Clonal Evolution in Acute Myeloid Leukemia from Diagnosis to Post-Transplant Follow-Up: The Role of Next-Generation SequencingAlessandra Sperotto, Maria Teresa Bochicchio, Giorgia Simonetti, et al.
Annals of Hematology|August 3, 2023
Reliability of flow-cytometry in diagnosis and prognostic stratification of myelodysplastic syndromes: correlations with morphology and mutational profileLuca Guarnera, Emiliano Fabiani, Cristina Attrotto, et al.
Annals of Hematology|February 24, 2022
Refractory primary immune thrombocytopenia (ITP): current clinical challenges and therapeutic perspectivesNicola Vianelli, Giuseppe Auteri, Francesco Buccisano, et al.
DNA Repair|May 15, 2007
Novel role of triazenes in haematological malignancies: pilot study of Temozolomide, Lomeguatrib and IL-2 in the chemo-immunotherapy of acute leukaemiaPatrizia Caporaso, Mario Turriziani, Adriano Venditti, et al.
Haematologica|September 2, 2004
Combined analysis of bcl-2 and MDR1 proteins in 256 cases of acute myeloid leukemiaAdriano Venditti, Giovanni Del Poeta, Luca Maurillo, et al.
Hematology (Amsterdam, Netherlands)|July 16, 2005
Apoptosis and immaturity in acute myeloid leukemiaMaria Ilaria Del Principe, Giovanni Del Poeta, Adriano Venditti, et al.
Multiple Sclerosis and Related Disorders|August 21, 2021
T-cell responses to SARS-CoV-2 in multiple sclerosis patients treated with ocrelizumab healed from COVID-19 with absent or low anti-spike antibody titersMarco Iannetta, Doriana Landi, Gaia Cola, et al.
Pageof 15

Showing results (31-40 of 143) with videos related to

Sort By:
Pageof 15
Leukemia|March 24, 2021
Measurable residual disease as a biomarker in acute myeloid leukemia: theoretical and practical considerationsRoland B Walter, Yishai Ofran, Agnieszka Wierzbowska, et al.
Mediterranean Journal of Hematology and Infectious Diseases|September 14, 2023
Therapy-related Myeloid Neoplasms: Considerations for Patients' Clinical EvaluationRaffaele Palmieri, Giovangiacinto Paterno, Flavia Mallegni, et al.
Frontiers in Immunology|May 13, 2017
FCγ Chimeric Receptor-Engineered T Cells: Methodology, Advantages, Limitations, and Clinical RelevanceSara Caratelli, Tommaso Sconocchia, Roberto Arriga, et al.
Biomedicines|February 25, 2023
Measurable Residual Disease and Clonal Evolution in Acute Myeloid Leukemia from Diagnosis to Post-Transplant Follow-Up: The Role of Next-Generation SequencingAlessandra Sperotto, Maria Teresa Bochicchio, Giorgia Simonetti, et al.
Annals of Hematology|August 3, 2023
Reliability of flow-cytometry in diagnosis and prognostic stratification of myelodysplastic syndromes: correlations with morphology and mutational profileLuca Guarnera, Emiliano Fabiani, Cristina Attrotto, et al.
Annals of Hematology|February 24, 2022
Refractory primary immune thrombocytopenia (ITP): current clinical challenges and therapeutic perspectivesNicola Vianelli, Giuseppe Auteri, Francesco Buccisano, et al.
DNA Repair|May 15, 2007
Novel role of triazenes in haematological malignancies: pilot study of Temozolomide, Lomeguatrib and IL-2 in the chemo-immunotherapy of acute leukaemiaPatrizia Caporaso, Mario Turriziani, Adriano Venditti, et al.
Haematologica|September 2, 2004
Combined analysis of bcl-2 and MDR1 proteins in 256 cases of acute myeloid leukemiaAdriano Venditti, Giovanni Del Poeta, Luca Maurillo, et al.
Hematology (Amsterdam, Netherlands)|July 16, 2005
Apoptosis and immaturity in acute myeloid leukemiaMaria Ilaria Del Principe, Giovanni Del Poeta, Adriano Venditti, et al.
Multiple Sclerosis and Related Disorders|August 21, 2021
T-cell responses to SARS-CoV-2 in multiple sclerosis patients treated with ocrelizumab healed from COVID-19 with absent or low anti-spike antibody titersMarco Iannetta, Doriana Landi, Gaia Cola, et al.
Pageof 15